Antileukemic Activity of Lysophosphatidic Acid Acyltransferase-β Inhibitor CT32228 in Chronic Myelogenous Leukemia Sensitive and Resistant to Imatinib

Paul La Rosée(Oregon Health & Science University), Michael W. Deininger(Oregon Health & Science University)
Clinical Cancer Research
November 1, 2006
10.1158/1078-0432.ccr-06-0140
Cited by 26

Related Papers

In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of Kit
|Blood|2005|61
Acute dasatinib exposure commits Bcr-Abl–dependent cells to apoptosis
|Blood|2009|59
JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera
|Blood|2019|35